These EVs expressed the monoclonal antibody αCD3 UCHT1, which is specific for CD3 T cells, and single-chain variable fragments of αEGFR cetuximab, which is specific for cancer cell-associated EGFR. This evidence concerns the gene EGFR and cancer.